These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 12795588)

  • 1. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
    Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
    Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry.
    Bauer SH; Zhang XY; Van Dongen W; Claeys M; Przybylski M
    Anal Biochem; 1999 Oct; 274(1):69-80. PubMed ID: 10527498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of ProPTHrP(1-141) by "prohormone thiol protease" at multibasic residues generates PTHrP-related peptides: implications for PTHrP peptide production in lung cancer cells.
    Hook VY; Burton D; Yasothornsrikul S; Hastings RH; Deftos LJ
    Biochem Biophys Res Commun; 2001 Jul; 285(4):932-8. PubMed ID: 11467841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
    Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
    Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules.
    Taylor CV; Taupenot L; Mahata SK; Mahata M; Wu H; Yasothornsrikul S; Toneff T; Caporale C; Jiang Q; Parmer RJ; Hook VY; O'Connor DT
    J Biol Chem; 2000 Jul; 275(30):22905-15. PubMed ID: 10781584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
    Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
    J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides.
    Biswas N; Rodriguez-Flores JL; Courel M; Gayen JR; Vaingankar SM; Mahata M; Torpey JW; Taupenot L; O'Connor DT; Mahata SK
    Endocrinology; 2009 Aug; 150(8):3547-57. PubMed ID: 19372204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel peptides from adrenomedullary chromaffin vesicles.
    Sigafoos J; Chestnut WG; Merrill BM; Taylor LC; Diliberto EJ; Viveros OH
    J Anat; 1993 Oct; 183 ( Pt 2)(Pt 2):253-64. PubMed ID: 8300415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
    Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
    Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2.
    Arden SD; Rutherford NG; Guest PC; Curry WJ; Bailyes EM; Johnston CF; Hutton JC
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):521-8. PubMed ID: 8141763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of natural vasostatin-containing peptides in rat heart.
    Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
    FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the proenkephalin processing enzyme prohormone thiol protease (PTP) as a multicatalytic cysteine protease complex: activation by glutathione localized to secretory vesicles.
    Yasothornsrikul S; Aaron W; Toneff T; Hook VY
    Biochemistry; 1999 Jun; 38(23):7421-30. PubMed ID: 10360939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS.
    Lee JC; Hook V
    Biochemistry; 2009 Jun; 48(23):5254-62. PubMed ID: 19405523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
    J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of chromogranin A by bovine parathyroid secretory granules: production and secretion of N-terminal fragments.
    Drees BM; Hamilton JW
    Endocrinology; 1994 May; 134(5):2057-63. PubMed ID: 8156905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
    Mahata SK; Mahata M; Wakade AR; O'Connor DT
    Mol Endocrinol; 2000 Oct; 14(10):1525-35. PubMed ID: 11043569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A: posttranslational modifications in secretory granules.
    Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
    Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands.
    Montero-Hadjadje M; Vaudry H; Turquier V; Leprince J; Do Rego JL; Yon L; Gallo-Payet N; Plouin PF; Anouar Y
    Cell Tissue Res; 2002 Nov; 310(2):223-36. PubMed ID: 12397377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an active site residue of the R1 subunit of ribonucleotide reductase from Escherichia coli: characterization of substrate-induced polypeptide cleavage by C225SR1.
    van der Donk WA; Zeng C; Biemann K; Stubbe J; Hanlon A; Kyte J
    Biochemistry; 1996 Aug; 35(31):10058-67. PubMed ID: 8756468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.